Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Forza Wealth Management LLC cut its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 5.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,817 shares of the biopharmaceutical company’s stock after selling 300 shares during the quarter. Forza Wealth […]
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) insider Merdad Parsey sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $72.96, for a total value of $145,920.00. Following the completion of the sale, the insider now owns 96,304 shares […]
Arvest Trust Co. N A lowered its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 126,058 shares of the biopharmaceutical company’s stock after selling 2,961 shares […]
Arvest Investments Inc. bought a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 11,380 shares of the biopharmaceutical company’s stock, valued at approximately $922,000. Other large investors also […]
Arvest Trust Co. N A lowered its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 126,058 shares of the biopharmaceutical company’s stock after selling 2,961 shares during […]